Highlights of Vitreoretina

Register      Login

VOLUME 6 , ISSUE 2 ( June, 2013 ) > List of Articles


Infección: El Papel Cambiante de los Antibióticos La Prevención de la Endoftalmitis Sigue Promoviendo el Debate entre los Oftalmólogos

Andrew M. Schimel, Harry W. Flynn Jr

Citation Information : Schimel AM, Flynn Jr HW. Infección: El Papel Cambiante de los Antibióticos La Prevención de la Endoftalmitis Sigue Promoviendo el Debate entre los Oftalmólogos. 2013; 6 (2):4-7.

DOI: 10.5005/hov-10102-06201

Published Online: 23-12-2020

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


PDF Share
  1. Kuehn B. Antibiotic Use Tracking. JAMA 2011;306(24):2661-2661.
  2. McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of antivascular endothelial growth factor agents: Causative organisms and possible prevention strategies. Retina 2011;31:654-661.
  3. Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr., et al. Endoph-thalmitis after intravitreal anti-vascular endothelial growth factor antagonists: A six-year experience at a university referral center. Retina 2011;31:662-668.
  4. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24(5 Suppl):S3-19.
  5. Wykoff CC, Flynn HW, Jr., Rosenfeld PJ. Prophylaxis for end-ophthalmitis following intravitreal injection: Antisepsis and anti-biotics. Am J Ophthalmol 2011;152:717- 719 e712.
  6. Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982;15:635-639.
  7. Hosseini H, Ashraf MJ, Saleh M, et al. Effect of povidone-iodine concentration and exposure time on bacteria isolated from endophthalmitis cases. J Cataract Refract Surg 2012;38:92-96.
  8. Ta CN, Egbert PR, Singh K, Shriver EM, et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 2002;109:2036-2040; discussion 2040-2031.
  9. Moss JM, Nguyen D, Liu YI, et al. Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora. Ophthalmology 2008;115:2013-2016.
  10. Callegan MC, Novosad BD, Ramadan RT, Wiskur B, Moyer AL. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Adv Ther 2009;26:447-454.
  11. Kim SJ, Toma HS, Midha NK, Cherney EF, et al. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: A prospective study of patients undergoing intravitreal injections. Ophthalmology 2010;117:2372-2378.
  12. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009;116:1498-1501.
  13. Halachmi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg 2009;35:2109-2114.
  14. Kim SJ, Toma HS. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol 2011;129:1180-1188.
  15. Mino De Kaspar H, Hoepfner AS, Engelbert M, et al. Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology 2001;108:470-478.
  16. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW, Jr. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol 2006;124:479-483.
  17. Hyon JY, Eser I, O'Brien TP. Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus. J Cataract Refract Surg 2009;35:1609-1613.
  18. Costello P, Bakri SJ, Beer PM, et al. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina 2006;26:191-195.
  19. Endophthalmitis Study Group, ESCRS. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007;33:978-988.
  20. Romero-Aroca P, Mendez-Marin I, Salvat-Serra M, Fernandez-Ballart J, et al. Results at seven years after the use of Intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC Ophthalmol 2012;12:2.
  21. Eifrig CW, Flynn HW Jr., Scott IU, Newton J. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers Sep- Oct 2002;33(5):373-378.
  22. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Arch Ophthalmol 2005;123:613-620.
  23. Montan PG, Wejde G, Setterquist H, Rylander M, et al. Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 2002;28:982-987.
  24. Mamalis N, Edelhauser HF, Dawson DG, Chew J, et al. Toxic anterior segment syndrome. J Cataract Refract Surg 2006;32:324-333.
  25. Gritz DC, Cevallos AV, Smolin G, Whitcher JP, Jr. Antibiotic supplementation of intraocular irrigating solutions. An in vitro model of antibacterial action. Ophthalmology 1996;103:1204-1208; discussion 1208-1209.
  26. Lehmann OJ, Thompson JP, White LO, Keys MF, Campbell MJ. Half-life of intracameral gentamicin after phacoemulsification. J Cataract Refract Surg 1997;23:883-888.
  27. Wykoff CC, Parrott MB, Flynn HW, Jr., Shi W, Miller D, Alfonso EC. Nosocomial acuteonset postoperative endophthalmitis at a university teaching hospital (2002-2009). Am J Ophthalmol 2011;150:392-398 e392.
  28. Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol 2011;129:1551- 1554.
  29. Doshi RR, Leng T, Fung AE. Reducing Oral Flora Contamination of Intravitreal Injections with Face Mask or Silence. Retina 2012;32:473-6.
  30. Schimel AM, Scott IU, Flynn HW, Jr. Endophthalmitis after intravitreal injections: Should the use of face masks be the standard of care? Arch Ophthalmol 2011;129:1607- 1609.
  31. Goldberg RA, Flynn HW Jr, Isom RF, Miller D, Gonzalez S. An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab. Am J Ophthalmol 2012;153:204-208.e1.
  32. Miller JJ, Scott IU, Flynn HW Jr., Smiddy WE, et al. Endoph-thalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol 2004;138:231-236.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.